Catheter Ablation

 

Wednesday, May 8

S-MC03. Ablation of Summit PVCs

Session Description: This session will discuss the different approaches that could be required in targeting summit PVCs. The anatomy and expert managed cases will be presented.

S-MC09. Extra-Cardiac Targets to Improve AF Outcomes

Session Description: Extra-cardiac risk factors contribute to the progression of AF. This session will highlight the current evidence for targeting these risk factors to improve AF outcomes.

 

Thursday, May 9

MP14. New lessons in SVT

Session Description: The abstracts in this session will present new information on the approach to SVT ablation. A global perspective on SVT is presented.

S-008. Current and Future Technologies to Make Catheter Ablation Safer

Session Description: Complications related to catheter ablation are inevitable, but many are avoidable. This session will highlight safer ways to use current technology and will introduce potential future safer technology.

S-001. Proof Beyond a Reasonable Doubt: We Need a Sham Trial for AF Ablation

Session Description: In this debate session, the presenters will argue for or against the need and utility of a clinical trial that includes a sham procedure group for evaluating ablation of atrial fibrillation.

S-016. Left Atrial Appendage Electrical Isolation Should Not Be Empirically Performed in Persistent and Longstanding Persistent AF at First Procedure

Session Description: This is a debate on the hot topic of empirical left atrial appendage electrical isolation in patients with persistent and long standing persistent atrial fibrillation: pro and cons.

S-JS04. Advanced Treatments of Complex Ventricular Arrhythmias

Session Description: This session will discuss recent progress for managements of complex ventricular tachyarrhythmias, including medical therapies, catheter and surgical ablation. A Joint Session presented by the Japanese Heart Rhythm Society (JHRS).

S-JS03. State-of-the-Art in Ablation of Ventricular Tachycardia in Nonischemic Cardiomyopathy

Session Description: This joint session with the European Heart Rhythm Association will cover advances in ablation of non-ischemic ventricular tachycardia, and cover topics from substrate mapping to new forms of therapy. A Joint Session presented by the European Heart Rhythm Association (EHRA).

S-027. Approach to Complex VT

Session Description: The expert will commence by giving a lecture, followed by case presentations unknown to the master. The audience will see how the master thinks aloud on these unknown cases followed by Q&A.

S-026. Decoding the Complex Atrial Flutter

Session Description: The ablation of atypical atrial flutter/tachycardia can be challenging. This session will provide an array of clinically challenging cases presented by high volume operators followed by detailed discussions from an expert panel.

MP15. Defining Substrate Based Ventricular Arrhythmias - Novel Approaches to Mapping

Session Description: This session will present abstracts on ventricular tachycardia mapping and ablation. It will utilize novel technologies and define their use.

S-041. Navigating the Difficult SVT — Tips From Experts

Session Description: SVT ablation can sometimes present challenges in terms of diagnosis and ablation location. This session highlights ways to safely overcome these challenges.

S-042. Persistent Atrial Fibrillation? What Are the Targets Beyond the PV Sleeves?

Session Description: This session will explore the relevance left atrium structures other than the PVs including the LAA, posterior wall, and the coronary sinus as triggers for AF. Likewise, this session will show the different techniques and energy sources to isolate these structures and achieve favorable long-term outcomes.

 

Friday, May 10

S-057. Substrate Based Ablation of Ventricular Arrhythmias

Session Description: In this session, presenters will explain different ablation strategies for treatment of ventricular arrhythmias, focusing on ventricular substrate. There will be descriptions of mapping techniques for identification of ventricular tissue involved in arrhythmogenesis and new mapping technologies for characterizing disease ventricular tissue.

S-058. What Do the Trials Say for Catheter Ablation?

Session Description: This session will review some of the recent catheter ablation trials and allow interaction with the trialist to expand on the results. The audience will be able to be up to date with catheter ablation trials and to listen about what's is on the way.

S-066. Evolving Endpoints of AF Ablation: Mortality, Hospitalization, AF Burden and Symptoms

Session Description: This session will feature some of the clinical trialist who have contributed to the evidence on endpoints of AF ablation. It will allow audience interaction to explore the varied outcomes in trials.

S-074. Approaches to Previously Failed Ablation of Ventricular Arrhythmias

Session Description: In this session, presenters will use a teaching cases to describe the approaches for mapping and ablation of challenging ventricular arrhythmias. There will be a focus on the use of imaging, biophysics, and ventricular substrate mapping.

S-075. What to Do After PVI for Persistent and Long Standing Persistent AF

Session Description: This session will explore the various substrates and approaches to improve the outcomes in persistent AF ablation. In addition, how targeting the impact of targeting concomitant conditions on ablation outcomes will be discussed.

S-JS13. LAHRS/HRS Joint Session: Catheter Ablation of Atrial Fibrillation: Is the Epicardium the Key to Improve the Results?

Session Description: The importance of the myofiber architecture to explain arrhythmogenesis was early proposed and catheter ablation techniques for AF have been in part developed based on this knowledge. However, the procedure still fails in a significant proportion of patients whose mechanisms are not completely understood. New clinical evidence and imaging methodologies have suggested a role of epicardial bundles to explain failed procedures. Detailed understanding of the endo-epi distribution of myocardial fibers and its correlation with clinical observations could help to design new approaches to improve the results of catheter ablation for AF.

MP16. Systemic Determinants of AF Ablation Outcomes and Complications

Session Description: This session features abstracts that describe the extracardiac factors that determine catheter ablation of AF outcomes and their complications.

S-090. The Difficult Mitral Isthmus Ablation — Aren't They All?

Session Description: This session addresses a common clinical problem during ablation of persistent or long-standing persistent atrial fibrillation - achieving mitral isthmus conduction block. Who should receive a mitral line, should it be anterior or posterior, should I use ETOh injection, or what if I isolate the LAA musculature?

S-091. Ablation Technologies of the Future

Session Description: This session highlights new ablation technology that is likely to be safer, quicker and more effective. Additionally, we will identify specific patients' scenarios where the new technology holds the greatest promise.

 

Saturday, May 11

S-101. How to Rapidly and Safely Isolate the Pulmonary Veins

Session Description: The session is aimed at identifying techniques to rapidly and safely isolate pulmonary veins with an emphasis on current technology.

S-109. How to Perform Epicardial VT Ablation

Session Description: Epicardial VT ablation is an increasingly performed yet technically challenging procedure for many electrophysiologists. This How-To session will focus on identifying candidates that are likely to benefit from this approach and the tools, techniques, and strategies that are used for epicardial access and ablation.

Exit Heart Rhythm Scientific Sessions

You are about to exit the Heart Rhythm Scientific Sessions website. Upon clicking the Continue button, you will be redirected to an external website.

Loading...

Continue